Safety and Therapeutic Efficacy of the Broadly Neutralizing HIV-1 Specific Monoclonal Antibody VRC01 During Analytic Treatment Interruption in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Latest Information Update: 04 Nov 2021
At a glance
- Drugs VRC 01 (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 24 Sep 2019 New trial record